Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Lessire

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biomed Research International|October 3, 2014
Management of non-vitamin K antagonist oral anticoagulants in the perioperative settingAnne-Sophie Dincq, Sarah Lessire, Jonathan Douxfils, et al.
Journal of Clinical Medicine|February 9, 2020
Reduction of Preoperative Waiting Time before Urgent Surgery for Patients on P2Y<sub>12</sub> Inhibitors Using Multiple Electrode Aggregometry: A Retrospective StudyMichaël Hardy, Camie Dupuis, Anne-Sophie Dincq, et al.
International Journal of Laboratory Hematology|July 12, 2021
Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulantsMichael Hardy, Claudia Dellanoce, Jonathan Douxfils, et al.
Frontiers in Cardiovascular Medicine|April 15, 2022
Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?Michael Hardy, Jonathan Douxfils, Anne-Sophie Dincq, et al.
Expert Opinion on Biological Therapy|July 22, 2017
Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or proceduresOvidiu Vornicu, Anne-Sophie Larock, Anne-Sophie Dincq, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2025
Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro studyMichael Hardy, Henri Thonon, Jonathan Douxfils, et al.
The American Journal of Medicine|June 28, 2021
The Impact of Strong Inducers on Direct Oral Anticoagulant LevelsAnne-Laure Sennesael, Anne-Sophie Larock, Philippe Hainaut, et al.
Clinical Cardiology|March 14, 2018
Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patientsAnne-Céline Martin, Sarah Lessire, Isabelle Leblanc, et al.
International Journal of Laboratory Hematology|January 4, 2019
Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasmaRomain Siriez, Jonathan Evrard, Jean-Michel Dogné, et al.
Journal of Clinical Medicine|March 10, 2022
Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity MeasurementBenjamin Lardinois, Michaël Hardy, Isabelle Michaux, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biomed Research International|October 3, 2014
Management of non-vitamin K antagonist oral anticoagulants in the perioperative settingAnne-Sophie Dincq, Sarah Lessire, Jonathan Douxfils, et al.
Journal of Clinical Medicine|February 9, 2020
Reduction of Preoperative Waiting Time before Urgent Surgery for Patients on P2Y<sub>12</sub> Inhibitors Using Multiple Electrode Aggregometry: A Retrospective StudyMichaël Hardy, Camie Dupuis, Anne-Sophie Dincq, et al.
International Journal of Laboratory Hematology|July 12, 2021
Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulantsMichael Hardy, Claudia Dellanoce, Jonathan Douxfils, et al.
Frontiers in Cardiovascular Medicine|April 15, 2022
Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?Michael Hardy, Jonathan Douxfils, Anne-Sophie Dincq, et al.
Expert Opinion on Biological Therapy|July 22, 2017
Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or proceduresOvidiu Vornicu, Anne-Sophie Larock, Anne-Sophie Dincq, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2025
Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro studyMichael Hardy, Henri Thonon, Jonathan Douxfils, et al.
The American Journal of Medicine|June 28, 2021
The Impact of Strong Inducers on Direct Oral Anticoagulant LevelsAnne-Laure Sennesael, Anne-Sophie Larock, Philippe Hainaut, et al.
Clinical Cardiology|March 14, 2018
Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patientsAnne-Céline Martin, Sarah Lessire, Isabelle Leblanc, et al.
International Journal of Laboratory Hematology|January 4, 2019
Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasmaRomain Siriez, Jonathan Evrard, Jean-Michel Dogné, et al.
Journal of Clinical Medicine|March 10, 2022
Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity MeasurementBenjamin Lardinois, Michaël Hardy, Isabelle Michaux, et al.
Pageof 3